{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:4725",
      "entity_text" : "PCV",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O60674",
      "entity_text" : "JAK2",
      "features" : [ {
        "to_base" : "V",
        "site" : 617,
        "feature_type" : "mutation",
        "evidence" : "V617F"
      } ],
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The finding of the acquired JAK2 V617F mutation and erythroid hyperplasia on BM biopsy allowed us to diagnose PCV in our asymptomatic patient despite a normal EPO level.",
  "reading_complete" : "2020-08-03T12:55:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:54:33Z",
  "trigger" : "allowed",
  "evidence" : [ "JAK2 V617F mutation and erythroid hyperplasia on BM biopsy allowed us to diagnose PCV" ],
  "pmc_id" : "5582235",
  "score" : 0
}